ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDV Indivior Plc

1,694.00
-11.00 (-0.65%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BN4HT335 ORD USD0.50
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -11.00 -0.65% 1,694.00 1,709.00 1,711.00 1,720.00 1,699.00 1,708.00 478,486 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.09B 2M 0.0148 1,154.05 2.31B

Indivior PLC Further statement re claim filed by RB (8416G)

30/11/2020 7:00am

UK Regulatory


Indivior (LSE:INDV)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Indivior Charts.

TIDMINDV

RNS Number : 8416G

Indivior PLC

30 November 2020

Indivior is providing the following statement pursuant to its initial statement dated November 27, 2020, related to a claim filed against it by Reckitt Benckiser Group.

Indivior PLC ("Indivior" or "the Company"), as an entitled party, has reviewed the claim Reckitt Benckiser Group ("RB") filed against the Company in the Commercial High Court in London on November 13, 2020. At the present time, the claim has not been served on the Company. Indivior notes reported comments by RB, as published in The Times and Financial Times newspapers on November 27, 2020, that RB "regularly takes certain procedural steps to preserve potential claims."

Based on the information available to it, Indivior strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served. If the claim is served, Indivior will fully and vigorously defend itself in any proceedings related to the claim.

Indivior will make further announcements as appropriate, including in relation to whether the claim is served.

For Further Information

 
 Investor Enquiries   Jason Thompson   VP, Investor             +1 804 402 7123 
                                        Relations Indivior       jason.thompson@indivior.com 
                                        PLC 
 Media Enquiries      Jonathan Sibun   Tulchan Communications   +44 207 353 4200 
                                        US Media Inquiries 
                                                                 +1 804 594 0836 
                                                                 Indiviormediacontacts@indivior.com 
 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FURBLBMTMTITTTM

(END) Dow Jones Newswires

November 30, 2020 02:00 ET (07:00 GMT)

1 Year Indivior Chart

1 Year Indivior Chart

1 Month Indivior Chart

1 Month Indivior Chart

Your Recent History

Delayed Upgrade Clock